CAMP4 Gross Profit from 2010 to 2025
| CAMP Stock | USD 5.27 0.01 0.19% |
Gross Profit | First Reported 2010-12-31 | Previous Quarter 60.3 M | Current Value 84.1 M | Quarterly Volatility 21.3 M |
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.26, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
CAMP4 | Gross Profit |
Latest CAMP4 THERAPEUTICS's Gross Profit Growth Pattern
Below is the plot of the Gross Profit of CAMP4 THERAPEUTICS PORATION over the last few years. Gross profit is a required income statement account that reflects total revenue of CAMP4 THERAPEUTICS PORATION minus its cost of goods sold. It is profit before CAMP4 THERAPEUTICS operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. CAMP4 THERAPEUTICS's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CAMP4 THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (37.93 M) | 10 Years Trend |
|
Gross Profit |
| Timeline |
CAMP4 Gross Profit Regression Statistics
| Arithmetic Mean | 111,791,769 | |
| Geometric Mean | 109,331,178 | |
| Coefficient Of Variation | 19.02 | |
| Mean Deviation | 15,854,972 | |
| Median | 122,405,000 | |
| Standard Deviation | 21,259,459 | |
| Sample Variance | 452T | |
| Range | 62.1M | |
| R-Value | (0.70) | |
| Mean Square Error | 248.9T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (3,112,805) | |
| Total Sum of Squares | 6779.5T |
CAMP4 Gross Profit History
Other Fundumenentals of CAMP4 THERAPEUTICS
CAMP4 THERAPEUTICS Gross Profit component correlations
Click cells to compare fundamentals
About CAMP4 THERAPEUTICS Financial Statements
CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 60.3 M | 84.1 M | |
| Gross Profit Margin | 0.32 | 0.25 |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.